A Clinical Study of 68Ga-HX01 Injection for PET Imaging
Status:
COMPLETED
Trial end date:
2023-10-30
Target enrollment:
Participant gender:
Summary
This is a single-center, open Phase I clinical study, consisting of two parts: a Phase Ia study in healthy adult subjects and a Phase Ib study in patients with malignant solid tumors.
Phase:
PHASE1
Details
Lead Sponsor:
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Collaborator:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology